Vigil Neuroscience Inc (NASDAQ:VIGL) has a beta value of 3.45 and has seen 1.21 million shares traded in the last trading session. The company, currently valued at $368.24M, closed the last trade at $7.89 per share which meant it gained $0.01 on the day or 0.13% during that session. The VIGL stock price is -0.76% off its 52-week high price of $7.95 and 83.4% above the 52-week low of $1.31.
The consensus among analysts is that Vigil Neuroscience Inc (VIGL) is Buy stock at the moment, with a recommendation rating of 3.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.47.
Vigil Neuroscience Inc (NASDAQ:VIGL) trade information
Sporting 0.13% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the VIGL stock price touched $7.89 or saw a rise of 0.13%. Year-to-date, Vigil Neuroscience Inc shares have moved 364.12%, while the 5-day performance has seen it change 0.13%. Over the past 30 days, the shares of Vigil Neuroscience Inc (NASDAQ:VIGL) have changed 275.71%.
Wall Street analysts have a consensus price target for the stock at $8, which means that the shares’ value could jump 1.38% from current levels. The projected low price target is $8.0 while the price target rests at a high of $8.0. In that case, then, we find that the current price level is -1.39% off the targeted high while a plunge would see the stock gain -1.39% from current levels.
Vigil Neuroscience Inc (VIGL) estimates and forecasts
The company’s shares have gained 162.13% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 0.00%.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -19.68% over the past 5 years. Earnings growth for 2025 is a modest 11.29% while over the next 5 years, the company’s earnings are expected to increase by 8.10%.
VIGL Dividends
Vigil Neuroscience Inc is expected to release its next earnings report in July this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Vigil Neuroscience Inc (NASDAQ:VIGL)’s Major holders
The top two institutional holders are ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC with over 5.84 million shares worth more than $23.35 million. As of 2024-06-30, ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC held 14.6419% of shares outstanding.
The other major institutional holder is NORTHPOND VENTURES, LLC, with the holding of over 4.21 million shares as of 2024-06-30. The firm’s total holdings are worth over $16.86 million and represent 10.5722% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and abrdn Life Sciences Investors . As of Mar 31, 2025 , the former fund manager holds about 1.52% shares in the company for having 710.14 shares of worth $5.6 million while later fund manager owns 528.47 shares of worth $4.17 million as of Dec 31, 2024 , which makes it owner of about 1.13% of company’s outstanding stock.
